Management ChangeMay 4, 2026, 04:17 PM
CooperCompanies Appoints Paul Keel as Independent Director
AI Summary
CooperCompanies announced the appointment of Paul Keel as an independent director to its Board of Directors, effective July 1, 2026. Mr. Keel will also serve on the Audit Committee. He brings extensive experience as a CEO in the medical device sector, having led Envista Holdings Corporation and Smiths Group plc, and held various leadership roles at 3M. The company expects his expertise to be a significant asset in executing its strategy and creating long-term value for stakeholders.
Key Highlights
- Paul Keel appointed as an independent director to CooperCompanies' Board of Directors.
- Appointment is effective July 1, 2026.
- Mr. Keel will also serve on the Audit Committee.
- He currently serves as President and CEO of Envista Holdings Corporation since 2024.
- Previously, he was CEO of Smiths Group plc from 2021 to 2024.
- He spent 16 years at 3M in various leadership roles, including Group President of 3M Consumer Business.
Price Impact
More from COO